Cargando…
Effect of Curcumin on Diabetic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Clinical Trials
BACKGROUND: Curcumin, a polyphenolic constituent from Curcuma longa, possesses antioxidant, hypolipidemic, and antidiabetic properties and has been reported to protect against diabetic kidney disease (DKD); however, the effect is inconsistent. OBJECTIVE: This systematic review and meta-analysis aime...
Autores principales: | Jie, Zhao, Chao, Mo, Jun, Ai, Wei, Shi, LiFeng, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660194/ https://www.ncbi.nlm.nih.gov/pubmed/34899954 http://dx.doi.org/10.1155/2021/6109406 |
Ejemplares similares
-
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
por: Ringman, John M, et al.
Publicado: (2012) -
Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study
por: Haroyan, Armine, et al.
Publicado: (2018) -
Effects of Turmeric and Curcumin Dietary Supplementation on Human Gut
Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study
por: Peterson, Christine T., et al.
Publicado: (2018) -
Randomized, placebo controlled, double blinded pilot superiority phase 2 trial to evaluate the effect of curcumin in moderate to severe asthmatics
por: Quan, Michele, et al.
Publicado: (2021) -
Effects of Curcumin Supplementation on Clinical Features and Inflammation, in Migraine Patients: A Double-Blind Controlled, Placebo Randomized Clinical Trial
por: Rezaie, Sheyda, et al.
Publicado: (2021)